The p53 tumor suppressor protein induces apoptosis in response to genotoxic and environmental stress. Recent studies have revealed the existence of a transcription-independent mitochondrial p53 apoptosis pathway, however the mechanism regulating p53 translocation to mitochondria and subsequent initiation of apoptosis was not known. Here, we show that Tid1, also known as mtHsp40 or Dnaja3, interacts with p53 and directs its translocation to mitochondria in cells exposed to hypoxia. Overexpression of Tid1 in tumor cells promoted mitochondrial localization of both wildtype and mutant forms of p53 and was able to restore the pro-apoptotic activity of mutant p53 proteins that were otherwise unable to induce apoptosis. Tid1's mitochondrial signal sequence and DnaJ domain were both required for the movement of the p53-Tid1 complex from the cytosol to the mitochondria. Our findings establish Tid1 as a novel regulator of p53 localization and apoptotic function.
Abstract
The p53 tumor suppressor protein induces apoptosis in response to genotoxic and environmental stress. Recent studies have revealed the existence of a transcription-independent mitochondrial p53 apoptosis pathway, however the mechanism regulating p53 translocation to mitochondria and subsequent initiation of apoptosis was not known. Here, we show that Tid1, also known as mtHsp40 or Dnaja3, interacts with p53 and directs its translocation to mitochondria in cells exposed to hypoxia. Overexpression of Tid1 in tumor cells promoted mitochondrial localization of both wildtype and mutant forms of p53 and was able to restore the pro-apoptotic activity of mutant p53 proteins that were otherwise unable to induce apoptosis. Tid1's mitochondrial signal sequence and DnaJ domain were both required for the movement of the p53-Tid1 complex from the cytosol to the mitochondria. Our findings establish Tid1 as a novel regulator of p53 localization and apoptotic function.
Apoptosis is an intrinsic cellular response to specific environmental stresses and occurs via p53-dependent and p53-independent mechanisms 1, 2 . Cells respond to hypoxia, DNA damage and oncogene deregulation by activating the p53-mediated cell death pathway. These stress stimuli rapidly lead to elevated cellular levels of p53 as p53 dissociates from MDM2, which normally targets its degradation [3] [4] [5] . While some p53
protein remains in the nucleus, a fraction also accumulates in the mitochondria, where it directly initiates an apoptotic program [6] [7] [8] . At the mitochondria, p53 forms complexes with members of the Bcl-2 protein family, which regulate the integrity of the mitochondrial membrane [9] [10] [11] . Mitochondrial p53 shifts the balance between anti-apoptotic and proapoptotic Bcl-2 family members, leading to release of cytochrome c into the cytoplasm, and initiation of the caspase proteolytic cascade, eventually resulting in cell death 12, 13 .
p53's ability to induce apoptosis at the mitochondria is independent of its transcriptional activity, as mutant p53 that lacks DNA binding capacity still retains the ability to induce apoptosis 14, 15 . Additionally, transfection of p53-null cells with mitochondrially targeted p53 proteins has been shown to induce apoptosis 16, 17 . Functional analysis of two common polymorphic variants of human p53, Arg72 and Pro72, has shown that the Arg72 variant not only induces apoptosis much more efficiently than the Pro72 variant, but is also localized to the mitochondria with greater efficiency 18 .
Although these findings clearly demonstrate that p53-mediated cell death occurs when p53 is localized in the mitochondria, the mechanisms involved in regulating the intracellular trafficking of p53 between the cytosol, the nucleus, and the mitochondria remain unclear. Chaperone proteins are suggested to stabilize and assist in the transport of p53 to the mitochondria. Mitochondrial Hsp40 (mtHsp40), also known as Tid1, contains a mitochondrial signal sequence in its amino-terminus and resides mainly in the mitochondria 19 . Prior to translocation into the mitochondria, Tid1 is retained in the cytosol, allowing for its interaction with cytosolic proteins. Since Tid1 also associates with Hsp70 and Hsp90
20
, which are known to form complexes with p53 21 , it is possible that Tid1 interacts directly or indirectly with p53. Observations that Tid1 functions both inside and outside of the mitochondria prompted us to address the possibility that Tid1 is involved in p53 trafficking. We have previously shown in breast cancer cell lines that Tid1
functions as a cochaperone with Hsp70, and that this interaction is essential for increasing proteasomal degradation of ErbB2 via the ubiquitination pathway 22 . Here, we hypothesized that by transporting p53 to the mitochondria, Tid1 acts as a critical regulator of p53-mediated apoptosis in response to environmental stresses. We found that Tid1 interacts with p53 and Hsp70 to form a multi-subunit complex that is responsible for guiding both mutant and wildtype p53 to mitochondria during initiation of the mitochondrial apoptotic pathway.
Results

Hypoxia induces p53 translocation to the mitochondria where it interacts with
Tid1 and mtHsp70
To determine whether p53 and Tid1 interact in the mitochondria under cellular stress, we subjected MCF-7 human breast cancer cells, which express wildtype p53, to oxidative stress and performed immunostaining to look for evidence of colocalization.
We chose to mimic hypoxia in these experiments, as hypoxic conditions frequently exist within solid tumors 23 , and thus apoptosis induced by hypoxic stress reflects the biology of solid tumors in vivo. Desferroxamine (DFX) is an iron chelator that mimics hypoxia by enhancing the accumulation of hypoxia-inducible factor 1 α (HIF1 α), which stimulates the transcription of hypoxia associated genes 24 . DFX upregulates p53 expression and induces rapid translocation of p53 into the mitochondria 10, 25 . Without DFX treatment, colocalization of p53 and Tid1 was rarely visualized due to the low levels of p53 in MCF-7 cells (Fig. 1a, upper panel) . However, when cells were treated with DFX, p53 levels increased (Fig. 1b) , and p53 co-localized with both Tid1 and Mitotracker (Fig. 1a, bottom panel). Similar results were observed with cells exposed to hypoxic stress using a gas pack pouch system, and cells treated with camptothecin to cause genotoxic stress (Suppl. Fig. 1 ). In contrast to altered p53 protein levels, immunoblotting of whole cell lysates demonstrated that DFX treatment had no effect on the protein levels of Tid1 and mtHsp70 (Fig. 1b) . The two bands observed in the Tid1 immunoblot represent alternatively spliced isoforms of Tid1 expressed in human cells: the long form: Tid1 L (43 kDa), and the short form, Tid1 S (40 kDa) 19, 26 .
To confirm the interaction of p53 and Tid1 using a biochemical approach, MCF-7 cells subjected to hypoxic stress were lysed and p53, Tid1, and mtHsp70 were immunoprecipitated from separate aliquots of whole cell lysates. Immunoblotting was performed using the indicated antibodies (Fig. 1c) . Consistent with Figure 1a , these experiments confirmed the presence of an interaction between Tid1 and p53, as Tid1 reciprocally co-immunoprecipitated with p53 in both the presence and absence of DFX.
Also consistent with previous reports describing an interaction between p53, Tid1, and mtHsp70 20, 21 , p53 and Tid1 were present in anti-mtHsp70 immunoprecipitates. In addition, untreated and DFX-treated MCF-7 cells were separated into nuclear, cytoplasmic and mitochondrial fractions to determine the subcellular distribution of p53 and Tid1. In untreated cells, p53 levels were undetectable by immunoblotting, whereas
Tid1 was detected only in mitochondrial fractions. Following DFX treatment, p53 levels increased and predominantly localized to mitochondria, although p53 was also found in the cytoplasm and nucleus in smaller amounts. Likewise, in DFX-treated cells, a majority of the Tid1 was found in the mitochondria, although smaller amounts of Tid1 protein were detected in cytosolic fractions (Fig. 1d , two upper panels). In addition to the two lower molecular weight bands attributable to the processed Tid1 L and Tid1 S isoforms, a third higher molecular weight band was detected in the cytosolic fraction representing the full-length, unprocessed precursor form of the Tid1 proteins (Tid1-UP).
The precursor form of Tid1 contains an amino-terminal presequence that directs its post-translational import into the mitochondrial matrix, where the targeting sequence is cleaved by the mitochondrial processing peptidase, generating the mature Tid1 protein (Tid1-P) 19, 27 . Under normal conditions, the precursor form of Tid1 is undetectable in total cell extracts by immunoblotting due to the small amount of precursor form, but when Tid1 is overexpressed or purified from the cytosolic fraction, this form becomes detectable. Immunoprecipitation of p53 from the different cellular fractions revealed that
Tid1 formed a complex with p53 in both the cytosol and mitochondria (Fig. 1d) .
Collectively these data demonstrate that p53 interacts with Tid1 in the cytoplasm and mitochondria in response to hypoxic stress.
Tid1 regulates p53 translocation into the mitochondria in response to cellular stress
Phosphorylation/acetylation modifications of p53 do not appear to be involved in its mitochondrial targeting, and p53 itself lacks a mitochondrial translocation motif 28, 29 .
We hypothesized that a mitochondrial trafficking factor that associates with p53 must be responsible for its translocation. Because Tid1 interacts with p53 in both the cytoplasm and mitochondria, we decided to investigate whether Tid1 directly modulates p53 translocation to the mitochondria under hypoxic stress. To do this, we examined the However, no difference in the transcriptional activity of p53 in control versus Tid1 knockdown cells was observed (Suppl. Fig. 3 ). At present, it is unclear why p53 localizes to the nucleus in Tid1 knockdown cells rather than remaining in the cytoplasm, and we are actively investigating possible mechanisms for this observation. Overall, the observation that Tid1 interacts with p53 ( Fig. 1) , and that changes in Tid1 expression levels significantly alter the subcellular distribution of p53 ( Fig. 2 ) strongly suggest that Tid1 functions as a mitochondrial trafficking factor, or at least as a cytosolic retention factor for p53.
Overexpression of Tid1 enhances p53-dependent apoptosis
To elucidate the functional significance of Tid1-mediated trafficking of p53 to the mitochondria, we investigated whether Tid1 knockdown or overexpression directly inhibited or promoted mitochondrial apoptosis in response to hypoxia. As shown in Fig This data is in agreement with the immunostaining data (Fig 2) illustrating the dependence of p53 mitochondrial localization on Tid1 expression, and strongly suggests that localization of p53 to mitochondria is required for hypoxia-induced apoptosis, and that this process is dependent on Tid1.
While hypoxic stress initiates apoptosis at the level of the mitochondria via the intrinsic pathway, mitochondrial cell death can also be stimulated by external stimuli, such as TNF or the Fas ligand 30 . Activation of the extrinsic pathway signals cell death through activation of caspase 8 and is p53-independent; in contrast, the intrinsic pathway is initiated at the mitochondria by the release of cytochrome c, which binds to caspase 9 to form the apoptosome 8 . Formation of the apoptosome leads to autoproteolytic processing and activation of caspase 9, and eventually other downstream caspases such as caspase 3, 6 and 7 31, 32 . Recent studies have demonstrated that MCF-7 lacks procaspase 3, however other caspases, such as caspase 6 or 7, can compensate in its absence 33, 34 , thus, MCF-7 cells can still undergo apoptosis through the intrinsic pathway. To verify that Tid1 regulated hypoxia-induced cell death through the intrinsic p53-mediated apoptotic pathway rather than through the p53-independent extrinsic pathway, two different apoptotic inhibitors, a caspase-8
inhibitor (Z-IETD-FMK) 35 and Bax-inhibitor peptide (BIP) 36 (which inhibit the extrinsic and intrinsic apoptosis pathways respectively) were tested to confirm which cell death pathway was activated in response to hypoxia. As summarized in 
Overexpression of Tid1 rescues the apoptotic activity of mutant p53
Tid1 itself is a tumor suppressor protein, and may exert its tumor suppressor activity by functioning as a cell death regulator 28, 37, 38 4b ). In contrast, no p53 protein or increase in apoptosis were observed even after DFX treatment in HCT116 p53 -/-cells. These results are consistent with the data from MCF-7 cells (Fig 1, 2 ) and confirm that Tid1 alone is insufficient to induce cell death and that p53 is required for this process. Furthermore, these results indicate that Tid1-mediated regulation of the p53-dependent mitochondrial apoptotic pathway is a previously unidentified mechanism of Tid1 tumor suppression.
The question of whether or not mutant forms of p53 can induce apoptosis remains controversial. One study reported that p53 mutants, unlike wildtype p53, were unable to form complexes with Bcl-2 in human cancer cells, were compromised in mediating outer mitochondrial membrane permeabilization and failed to undergo apoptosis 39 . In contrast, others have found that cells harboring the R273H, Gln22, Ser23, or various other p53 mutants can still undergo apoptosis 40, 41 . It is possible that mutant p53 can mediate apoptosis at the mitochondria through additional Bcl-2-independent mechanisms; for example, mutant p53 also directly binds with other proapoptotic proteins such as BAX in response to cellular stress 42 . We investigated whether or not Tid1 was still able to interact with mutant p53 and direct its translocation to the mitochondria by co-infecting HCT116 p53 -/-cells with Ad-p53 wt or Ad-p53
mt -121F
and Ad-Tid1 or Ad-Scramble. p53 mt-121F contains a mutated DNA binding domain, and has been used in previous studies of p53-mediated apoptosis 43 . When the extent of hypoxia-induced apoptosis was assessed in these cells, we found that p53-mediated apoptosis was significantly rescued in p53 mt -121F infected cells overexpressing Tid1 ( ), SK-BR-3
(p53 mt-R175H ), and BT474 (p53 mt-E285K ) 44 , and the glioma cell lines, U87 (p53 wt ), and U373
(p53 mt-R273H ) 45 . As indicated in Fig. 5a , the breast cancer and glioma cells expressed high levels of several different forms of mutant p53, which have been shown to lack transcriptional activity 44, 45 . We observed that Tid1 protein levels in p53 mutant cancer cell lines were substantially lower than the protein levels observed in p53 wildtype cancer cells (Fig. 5a) , correlating with the lower levels of apoptosis observed in response to hypoxia. To evaluate the effect of Tid1 expression levels, each cell line was infected with Ad-Tid1 S (Fig. 5b) . As shown in Fig.5c , cancer cells with mutant p53 that expressed only endogenous levels of Tid1 (white arrows) showed nuclear localization of p53, while overexpression of Tid1 in these cells (yellow arrows) caused mutant p53 to move to the mitochondria in the vast majority of infected cells. Furthermore, cells expressing mutant p53 underwent spontaneous apoptosis when Tid1 was overexpressed (Fig. 5d ), but did not exhibit significant levels of apoptosis in the absence of Tid1 overexpression or DFX treatment (Suppl. Fig.4) . Overall, these results suggest that Tid1 overexpression can restore the p53-mediated apoptotic response in cancer cells with mutant p53.
Cytosolic retention of mutant Tid1 can inhibit p53-mediated apoptosis
Tid1 is comprised of several distinct functional domains: an amino-terminal signal sequence (NT), a DnaJ-domain, a glycine-and phenylalanine rich region (G/F), a cysteine-rich domain (CXXCXGXG), and a carboxy-terminal domain (CT) (Fig. 6a ) 21 .
We predicted that several of these domains would be required for successful translocation of p53 to mitochondria and induction of apoptosis in response to hypoxia.
Like most mitochondrial matrix proteins encoded by nuclear DNA, both Tid1 L and Tid1 S have a predicted mitochondrial processing sequence (LRP-GV) in the NT domain 21 , resulting in cleavage at amino acid 66 upon entry into the mitochondria. Hence, loss of the NT domain would be expected to inhibit mitochondrial translocation and apoptosis downstream of p53. In addition, Tid1 is known to interact with mtHsp70 through its conserved DnaJ domain 20 , and mtHsp70 interacts with p53 ( Fig. 1 )Thus, we also predicted that the DnaJ domain of Tid1 would be required for p53 binding and subsequent translocation to the mitochondria during hypoxia. To test these predictions, we used adenoviral constructs to overexpress wildtype or mutant Tid1 (Fig. 6a ) in MCF- In accordance with these results, immunostaining with p53 demonstrated that little, if any, overexpressed Tid1-ΔNT or Tid1-HQ co-localized with Mitotracker (Fig. 6c) .
Moreover, the retention of p53 in the cytosol significantly decreased the amount of apoptosis observed (compare Ad-Tid1s vs. Ad-ΔNT or Ad-HQ in Fig. 6d ), confirming that p53 localization to the mitochondria is required for hypoxia-induced apoptosis. In summary, ablation of the mitochondrial targeting sequence or mutation of the DnaJ domain of Tid1 restricted p53 localization to the cytosol, although it had no effect on the expression levels of p53 (Fig. 6b, 6c ). These data indicate that both the NT and the DnaJ domain of Tid1 are required for p53-mediated apoptosis and strongly suggest that Tid1 is a key factor in p53 mitochondrial translocation and cell death signaling.
Discussion
Many tumors contain p53 mutations, but whether or not tumor cells harboring mutant p53 have an impaired p53-mediated apoptosis pathway remains controversial.
In the nucleus, p53 mediates its cellular functions through its ability to regulate the transcription of multiple target genes, including many that promote either cell cycle arrest or apoptosis 1,2, 32 . However, a growing amount of evidence points to a direct role for p53 in a transcription-independent mitochondrial apoptosis pathway. For example, several other groups have reported that p53 Gln22Ser23 , which is completely deficient in the ability to activate or repress transcription, can still induce apoptosis 6 . Our studies provide experimental evidence that cancer cells expressing several different p53 mutants have an intact mitochondrial p53-mediated apoptotic pathway, and that successful p53 translocation to the mitochondria is sufficient for apoptosis to occur. By mediating this translocation event, Tid1 expression is able to promote hypoxia-induced apoptosis in cancer cells expressing both mutant and wildtype p53.
In conclusion, we have shown that Tid1 is a novel regulator of p53-mediated apoptosis. Under normal conditions, p53 forms a complex with MDM2 and is rapidly degraded by polyubiquitylation. However, when cells are subjected to genotoxic or environmental stresses such as hypoxia, p53 dissociates from MDM2, leading to the upregulation of p53 protein levels. When this occurs, p53 is then free to form a complex with Tid1 and mtHsp70, which is directed to the mitochondria where p53 initiates apoptosis (Fig. 7) . On the other hand, in many cancer cells p53 mutations decrease p53 degradation, leading to elevated basal levels of p53 that, nevertheless, lack apoptotic potential. This is likely due, at least in part, to the fact that cells with mutant p53 often also express smaller amounts of Tid1 protein, which prevents efficient localization of p53 to the mitochondria and induction of apoptosis in these cells. This model is supported by our observation that overexpressing Tid1 in cells with mutant p53 was sufficient to rescue both the mitochondrial localization of p53 and the ability of the cells to undergo apoptosis. Overall, we have clearly shown that Tid1 is a novel regulator of the p53-mediated apoptosis pathway activated in the early stages of the stress response. This finding has direct clinical relevance as it suggests that cancer therapeutics that increase Tid1 expression levels in cancer cells may be a novel means of promoting apoptosis in tumors that express either wildtype or mutant forms of p53.
Methods
Cell lines and Treatments
The human breast cancer cell lines, MCF-7 (p53 wt ), T47D (p53 Propidium iodide (PI, blue) was used for nuclear staining. . Forty-eight hours following infection, cells were treated with 125 μM DFX for 6 hours, and then apoptosis was measured using the in situ TUNEL assay. 
